Shares of medical device company InMode (NASDAQ: INMD) fell 32% in April, according to data provided by S&P Global Market Intelligence . On April 11, the company gave encouraging preliminary financial results for the first quarter of 2022. But the stock ultimately underperformed the market average by a wide margin and is currently down roughly 75% from its all-time high in 2021.
Oddly enough, prominent analysts applauded the Q1 results from InMode but lowered their expectations for the stock nevertheless.
For further details see:
This Is Why InMode Stock Fell 32% in April